OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Advance planning is essential to ensure a reliable supply for parenteral drug packaging
Consistency, robustness, and API-excipient understanding are essential for successful drug release.
Despite challenges caused by COVID-19, M&A activity in life sciences is recovering well.
Intelligent analytical tools detect impurities in small-molecule drug ingredients.
Okra gum serves as a polymer for oral drug formulations.
Microbial experts should employ proactive practices on the manufacturing floor.
UK Approves Moderna for Adolescents; Updates on Solidarity Plus Trial
September 16, 2021
The joint venture with OSTHUS will expand PharmaLex’s IT consulting and system integration expertise.
CPC’s MicroCNX Series Connectors provide an alternative to tube welding at small tubing sizes.
AzurRx’s acquisition of First Wave Bio grants them access to their proprietary niclosamide formulations.
FDA and EMA will provide scientific advice to applicants concerning complex generic and hybrid products.
September 14, 2021
Repligen and Navigo’s novel ligand could be the first to address antibody aggregation in low pH elution buffers.
AGC Biologics is expanding manufacturing capacity at its Heidelberg, Germany, facility for plasmid DNA and messenger RNA.
HUTCHMED’s amdizalisib (HMPL-689) received breakthrough therapy designation for the treatment of a subtype of non-Hodgkin’s lymphoma.
Both Marion Gruber and Phillip Krause, FDA officials, co-authored a document disputing the need for COVID-19 boosters for most people.
September 13, 2021
The memorandum of understanding between ABITEC and Luca AICell will work to advance ultra-high purity lipidic chemistries.
Boehringer Ingelheim and Twist Bioscience will use Twist’s antibody libraries to discover therapeutic antibody candidates.